<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23">
 <label>23.</label>
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Elmezayen</surname>
    <given-names>AD</given-names>
   </name>
   <name>
    <surname>Al-Obaidi</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Sahin</surname>
    <given-names>AT</given-names>
   </name>
   <name>
    <surname>Yelek√ßi</surname>
    <given-names>K</given-names>
   </name>
  </person-group>. 
  <article-title>Drug repurposing for coronavirus (COVID-19): 
   <italic>in silico</italic> screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
  </article-title>. 
  <source>J Biomol Struct Dyn.</source> (
  <year>2020</year>). 
  <pub-id pub-id-type="doi">10.1080/07391102.2020.1758791</pub-id>. [Epub ahead of print].
  <?supplied-pmid 32306862?>
 </mixed-citation>
</ref>
